Vaccine Rollout Comes With S Challenge

Chris Manfuso is the national director of sales at Enovachem Pharmaceuticals, a role in which he is responsible for guiding the company to cooperate with the industries it serves. Chris Manfuso and Enovachem Pharmaceuticals are currently engaged with R&D into medicine for pain relief, but are also cognisant of the ongoing fight against COVID-19.

All over the world the development of a vaccine against COVID-19 was the goal for anyone who could feasibly do so. The task was successful, with even communist Cuba achieving a vaccine with a 92% effectiveness rate without a direct financial incentive. Although vaccines are widely available, there is constant debate on who should have them and why.

Even as the vaccine rolls out worldwide, questions continuously emerge about who it is safe to provide the vaccine for or even who should get the vaccine at all. Many pharmaceutical, federal, and scientific organizations feel the responsibility of continuously proving the safety of the vaccine to answer such questions; for example, the New England Journal of Medicine found in April of 2021 that the Pfizer vaccine is safe for pregnant women.

Enovachem Creates SUIK in Response to

Chris Manfuso is the national director of sales for Enovachem Pharmaceuticals in Torrance, California. Here, Chris Manfuso devises strategies for business development, generating revenue, and marketing, among other activities.

Enovachem Pharmaceuticals partnered with the CDC’s One & Only Campaign and creating the Single Use Injection Kits (SUIK). In 2016, the pharmaceutical company became a member of the CDC’s One & Only Campaign, which is a campaign that promotes safe injection practices in all healthcare settings.

The SUIK were been designed to be used once per patient. Moreover, healthcare providers can track the injection's ingredients in case a patient suffers from adverse reactions or the product’s manufacturers issue a recall. The product also allows for smart communication between healthcare providers and staff members as it relates to the selection of proper injection kits.

The product includes a patented color-coded system that distinguishes between solutions that are corticosteroids and anesthetics. The company has 31 types of SUIK kits, which can be found at https://enovachem.us.com/product-category/enovarx-suik/.

PeacePlayers Releases 2020 Impact Report

The national director of sales at the Nubratori RX pharmaceutical manufacturing company, Chris Manfuso oversees business development initiatives to improve the product sales and distribution of the company. To give back to the community, Chris Manfuso contributes to important charitable initiatives such as PeacePlayers, an organization that seeks to bring diverse communities together through the power of sports.

PeacePlayers recently released a 2020 Impact Report to share the results of its efforts over the past year. The report features impact figures from the many countries and regions all over the world in which PeacePlayers operates, including the U.S.

Benefiting from a partnership with Nike, PeacePlayers has worked to carry out its mission in the U.S. since 2017. Over this period, it estimates 2,000 youth have participated in its programs, as well as 45 community partners. In 2020, it implemented strategies to bring together people of different ethnic and cultural backgrounds living in Chicago, Detroit, Los Angeles, Brooklyn, and Baltimore. The Impact Report showed 100 percent of its Brooklyn and Detroit youth participants were able to experience something out of the ordinary through the programming.

In Chicago, 75 percent of youth participants reported they had increased leadership skills after taking part in PeacePlayers for a single year. Despite these statistics, the Impact Report also stated “a systematic culture of racism” continues to create a crisis in the U.S.

Enovachem Pharmaceuticals and the EnovaRX Single-Use Injection Kit

Entrepreneur Chris Manfuso specializes in healthcare management and the provision of ancillary services. In 2020, Chris Manfuso became the national director of sales at Enovachem Pharmaceuticals, a developer and manufacturer of pharmaceutical products in Torrance, California.

An FDA-registered and CGMP- and CFR-compliant pharmaceutical manufacturing facility, Enovachem distributes patented and patent-pending EnovaRX products. The EnovaRX unique brand only offers a portfolio of kits that have been accepted by renowned database platforms, including Redbook and Medi-span.

EnovaRX Single-Use Injection Kits (SUIK), for instance, were created to support the CDC One and Only Campaign, which promotes the one-time use of each needle and syringe. Enovachem’s SUIK can track the active ingredients in an injection and facilitate recall from manufacturers in cases of adverse patient reactions.

The EnovaRX SUIK also comes with a patented color-coded system to help healthcare professionals identify the injectable solution and maintain quality control. One of the available kits is the Betaloan SUIK that comes with two injectable medications, two syringes and needles, and preparation supplies, such as sterile gloves, adhesive bandages, and a face mask.